All Articles

As John Deere preps for its Q3 earnings, all eyes are on whether its tech pivot and construction strength can offset a soft farm economy. We break it down.

Soprano Eleonora Buratto lends her voice to fight 'butterfly disease,' highlighting an innovative venture philanthropy model rewriting the playbook for rare illnesses.

For decades, signed contracts were a data graveyard. A new tool from legal AI leader GC AI promises to change that, turning static documents into a queryable goldmine.

A landmark deal between Boston Globe Media and Freestar reveals a new strategy for publishers: focusing on journalism by letting ad tech experts run monetization.

A new pilot pairs a finance giant with a crypto network to solve the biggest hurdle for digital assets: scalable compliance. Is this the key to unlocking global stablecoin adoption?

e& UAE deploys Ciena's groundbreaking 1.6Tb/s optical tech, building a future-ready network to power the Middle East's AI and hyperscale ambitions.

Athelas claims its 'agentic' AI suite will revolutionize clinic operations. The Anderson Analysis digs into the tech, the 10x claims, and the human cost.

As Culver's expands at a breakneck pace, its new partnership with Armada reveals a critical lesson: the future of foodservice is won in the warehouse.

MatSing has cracked the code on large-format Luneburg Lenses, a breakthrough set to transform satellite links, defense systems, and next-gen wireless.

A new federal directive urges states to phase out mercury dental fillings in Medicaid, a strategic shift impacting millions and aligning U.S. policy with global health goals.

Beyond market tailwinds, Franklin Templeton's record assets reveal a deliberate strategy of acquisition, a pivot to alternatives, and key tech innovation.

As AI agents begin to manage billions in ad spend, PubMatic's new framework offers a critical layer of control. Is this the key to unlocking trust?

Colossal’s new fund pairs genetic engineering with grassroots conservation, offering a high-tech, high-stakes lifeline to species from ferrets to sea stars.

Acrivon's ACR-2316 shows durable responses in lung cancer, moving to the next phase. The trial's design, guided by AI, aligns with new FDA standards.

TestMu AI is giving developers a head start on Samsung's new Z Fold8 and Fold8 Ultra, using agentic AI to solve the complex challenge of their opposing designs.

The logistics giant heads to a key summit with strong results, but can it prove its 'Lean AI' is a real competitive moat and not just market buzz?

Ad tech firm Shirofune is launching 'Creative Timeline,' a patent-pending AI feature designed to end creative silos and make ad performance data intuitive.

The mobile tech firm appoints a seasoned corporate finance and crypto veteran, signaling a new era focused on strategic growth and financial engineering.

As insurers move from AI experiments to enterprise-wide adoption, a new category of software is emerging to manage the chaos. Here's what it means for the industry.

Bristol Myers Squibb's large-scale deployment of Schrödinger's Bunsen AI isn't just a software deal; it's a strategic signal for the future of pharma R&D.